论文部分内容阅读
1996年,我国将壳聚糖研发项目列入九五攻关计划,后被列入863计划。经中国科学院微生物研究所,中国医学科学院药用植物研究所,北京大学生命科学中心联合研制开发,一举攻克了壳聚糖脱乙酰度和水溶性的难关,解决了人体高效吸收的问题,取得了处于国际领先地位的技术突破,获取中国专利:ZL961010770。作为合作伙伴的珠海市华辰生物工程有限公司拥有全部知识产权,申报注册为华康壳聚糖。2001年,华康牌水溶性壳聚糖(胶囊)的制备方法,获得中国专利技术博览会金奖,并通过ISO9001-2000国际质量管理体系认证。2002年1月,华康壳聚糖胶囊被中国
In 1996, Chinas chitosan research and development projects included in the Ninth Five-Year Research Project, was included in the 863 plan. The Chinese Academy of Sciences Institute of Microbiology, Chinese Academy of Medical Sciences Institute of Medicinal Plant, Peking University Life Science Center jointly developed in one fell swoop to overcome the chitosan deacetylation and water-soluble difficulties to solve the problem of human absorption and achieved In the international leader in technological breakthroughs, access to Chinese patent: ZL961010770. Zhuhai Huachen Bioengineering Co., Ltd., as a partner, owns all the intellectual property rights and declares and registers as Huakang Chitosan. In 2001, Wacker brand water-soluble chitosan (capsule) preparation method, access to China Patent Technology Exposition Gold Medal, and passed ISO9001-2000 international quality management system certification. January 2002, Huakang chitosan capsules by China